How to Hire an Attorney for Drugs and Medical Devices Cases
1. Confirm regulatory and litigation experience specific to pharmaceuticals, biologics, and devices
Ask whether the attorney routinely handles matters for drug manufacturers, biotech firms, device makers, contract research organizations (CROs), or healthcare providers, and request concrete examples: FDA warning‑letters responses, pre‑submission meetings (pre‑IND, pre‑IDE, Q‑subs), 510(k)/PMA or ANDA filings, REMS design and negotiation, or post‑market enforcement (recalls, mandatory reporting, MDRs, adverse event responses). For litigation matters, ask for pleadings and outcomes in Hatch‑Waxman/ANDA patent litigations, product‑liability suits, off‑label promotion cases, False Claims Act (FCA) defense or qui tam matters, and enforcement actions by FDA, DOJ, or state attorneys general. Confirm they know the regulatory pathway applicable to your product (drug, biologic, combination product, or class of device) and the evidentiary standards for safety/effectiveness, substantial equivalence, and labeling claims. Specific knowledge of agency guidance documents, relevant CFR sections, and recent precedent (e.g., preemption decisions, labeling liability rulings) is essential to craft regulatory strategy and defend against enforcement or civil exposure.
2. Verify technical teams, data‑forensics, and early‑stage preservation and compliance tactics
These matters require scientific and data depth. Ask who the firm routinely retains, regulatory scientists, pharmacovigilance specialists, clinical-trial statisticians, GMP/GLP auditors, biomedical engineers, and expert toxicologists, and request examples where such experts materially changed the outcome (e.g., reanalysis of safety data that narrowed signal concerns, successful remediation after GMP citation, or expert affidavits supporting a 510(k) substantial‑equivalence argument). Confirm the attorney’s approach to early preservation: immediate forensic collection of trial databases, eCRFs, batch records, validation and change‑control documentation, device design history files, complaint files, and complaint handling timelines. For potential recalls or safety signals, ensure they have a playbook for coordinating with quality teams to run root‑cause analyses, implement corrective and preventive actions (CAPAs), prepare recall communications, and manage press/physician notifications while minimizing admissions. Also probe their experience with data issues, statistical analysis plans, interim safety analyses, data‑monitoring‑committee interactions, and defending clinical‑trial integrity challenges (randomization/process deviations, missing data handling).
3. Get a clear, phase‑based engagement: fees, risk allocation, and multi‑forum enforcement strategy
Demand a written engagement that maps services to phases: pre‑market regulatory advice and filing support, trial design and compliance, post‑market surveillance and signal management, regulatory enforcement response, product‑liability defense or counseling on mass‑tort exposure, and appellate/parallel administrative proceedings. For fees, negotiate stage‑specific pricing: fixed fees for discrete regulatory filings or label changes, capped budgets for enforcement response and discovery, and blended/hourly for litigation‑intensive phases; explicitly state which third‑party costs (expert analyses, lab retesting, batch reanalysis, data hosting) the firm will advance and the pre‑approval thresholds. Insist on a multi‑jurisdictional plan: mapping FDA and state regulator risks, coordinating with foreign regulators if marketed abroad, and planning for parallel civil litigation or class actions (venue strategy, MDL awareness, global discovery coordination). Finally, require a documented risk‑mitigation plan covering disclosure timing (when to inform regulators vs. customers), insurance coordination (product liability, recall insurers), and remediation playbooks (containment, CAPA, supplier management) so legal advice is integrated with technical and business decision‑making under time pressure.
